Fulgent Genetics, Inc. (FLGT)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 20.72 |
| Open | 20.81 |
| Bid | 20.03 x 100 |
| Ask | 20.13 x 200 |
| Day's range | 20.08 - 20.88 |
| 52-week range | 20.07 - 44.09 |
| Volume | |
| Avg. volume | 213,566 |
| Market cap | 600.705M |
| Beta (5Y monthly) | 1.42 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.63 |
| Earnings date | 03 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 26.67 |
Business WireFulgent Genetics to Announce First Quarter 2024 Financial Results on Friday, May 3, 2024
EL MONTE, Calif., April 11, 2024--Fulgent Genetics, Inc. (NASDAQ: FLGT) ("Fulgent" or the "Company"), a technology-based company with a well-established laboratory services business and a therapeutic development business, today announced that it will release its first quarter 2024 financial results before the market opens on Friday, May 3, 2024. Management will host a conference call for the investment community the same day at 8:30 AM ET (5:30 AM PT) to discuss the results and answer questions.
Simply Wall St.Fulgent Genetics (NASDAQ:FLGT) shareholders have earned a 26% CAGR over the last five years
Fulgent Genetics, Inc. ( NASDAQ:FLGT ) shareholders might be concerned after seeing the share price drop 25% in the...
- Simply Wall St.
An Intrinsic Calculation For Fulgent Genetics, Inc. (NASDAQ:FLGT) Suggests It's 32% Undervalued
Key Insights The projected fair value for Fulgent Genetics is US$33.29 based on 2 Stage Free Cash Flow to Equity...
© 2024 Yahoo. All rights reserved.